printer-friendly
American Society of Hematology BMT Presentations: November 2009
Reduced Relapse and Similar Progression-Free Survival After Double Umilical Cord Blood Transplant: Comparisons of Outcomes Between Sibling, Unrelated Adult and Unrelated Donor UCB HSC Donors -- Claudio Brunstein, M.D.
Selection of Donors with Favorable KIR B Genetypes for Unrelated HCT Results in Superior Relapse Protection and Beter Relapse-Free Survival for Patients with AML -- Jeffrey Miller, M.D.
Monosomal Karyotype Provides Better Prognostic Prediction After Allogeneic SCT in AML Patients -- Betul Oran, M.D.
Delayed Platlet Recovery after Allogeneic Periferal Blood, Marrow and Umilical Cord SCT: Risk Factors and Clinical Outcomes -- Pablo Ramirez, M.D.
DNA Repair Plymorphisms: Implications for HCT Outcomes -- Mukta Arora, M.D.
